Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Change in Receivables (2021 - 2024)

Historic Change in Receivables for IDEAYA Biosciences (IDYA) over the last 4 years, with Q4 2024 value amounting to -$17000.0.

  • IDEAYA Biosciences' Change in Receivables rose 9974.57% to -$17000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was -$15000.0, marking a year-over-year increase of 9222.8%. This contributed to the annual value of -$15000.0 for FY2024, which is 9222.8% up from last year.
  • Latest data reveals that IDEAYA Biosciences reported Change in Receivables of -$17000.0 as of Q4 2024, which was up 9974.57% from $19000.0 recorded in Q3 2024.
  • IDEAYA Biosciences' Change in Receivables' 5-year high stood at $6.5 million during Q3 2023, with a 5-year trough of -$6.7 million in Q4 2023.
  • For the 4-year period, IDEAYA Biosciences' Change in Receivables averaged around -$117125.0, with its median value being -$15500.0 (2024).
  • The largest annual percentage gain for IDEAYA Biosciences' Change in Receivables in the last 5 years was 112964.17% (2022), contrasted with its biggest fall of 390941.18% (2022).
  • IDEAYA Biosciences' Change in Receivables (Quarter) stood at $85000.0 in 2021, then crashed by 3909.41% to -$3.2 million in 2022, then tumbled by 106.45% to -$6.7 million in 2023, then skyrocketed by 99.75% to -$17000.0 in 2024.
  • Its Change in Receivables was -$17000.0 in Q4 2024, compared to $19000.0 in Q3 2024 and -$14000.0 in Q2 2024.